ZVTKNSHRQMTISW-ADSBAMQRSA-N
C36H30F8N4O5 — CID 118030756
Data last refreshed: (MolForge compound catalog, from PubChem)
About ZVTKNSHRQMTISW-ADSBAMQRSA-N
ZVTKNSHRQMTISW-ADSBAMQRSA-N (PubChem CID 118030756) has the molecular formula C36H30F8N4O5 and a molecular weight of 750.64 g/mol. Its IUPAC name is 4-[5-[2-[[(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-1,3-oxazolidin-3-yl]methyl]-6-(3,3-difluoroazetidin-1-yl)-3-pyridinyl]-6-methoxy-3-pyridinyl]-3,5-dimethylbenzoic acid.
Molecular Properties
| Compound Name | ZVTKNSHRQMTISW-ADSBAMQRSA-N |
|---|---|
| PubChem CID | 118030756 |
| Molecular Formula | C36H30F8N4O5 |
| Molecular Weight | 750.64 g/mol |
| Exact Mass | 750.21 |
| IUPAC Name | 4-[5-[2-[[(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-1,3-oxazolidin-3-yl]methyl]-6-(3,3-difluoroazetidin-1-yl)-3-pyridinyl]-6-methoxy-3-pyridinyl]-3,5-dimethylbenzoic acid |
| SMILES | COc1ncc(-c2c(C)cc(C(=O)O)cc2C)cc1-c1ccc(N2CC(F)(F)C2)nc1CN1C(=O)O[C@H](c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@@H]1C |
| InChI | InChI=1S/C36H30F8N4O5/c1-17-7-21(32(49)50)8-18(2)29(17)22-11-26(31(52-4)45-13-22)25-5-6-28(47-15-34(37,38)16-47)46-27(25)14-48-19(3)30(53-33(48)51)20-9-23(35(39,40)41)12-24(10-20)36(42,43)44/h5-13,19,30H,14-16H2,1-4H3,(H,49,50)/t19-,30-/m0/s1 |
| InChIKey | ZVTKNSHRQMTISW-ADSBAMQRSA-N |
| XLogP | 8.71 |
| TPSA | 105.09 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 53 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 750.64 |
| LogP ≤ 5 | 8.71 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118030756 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.